Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Revenue

Entrada Therapeutics had revenue of $1.61M in the quarter ending September 30, 2025, a decrease of -91.75%. This brings the company's revenue in the last twelve months to $61.52M, down -71.42% year-over-year. In the year 2024, Entrada Therapeutics had annual revenue of $210.78M with 63.38% growth.

• Revenue (ttm): $61.52M
• Revenue Growth: -71.42%
• P/S Ratio: 7.66
• Revenue / Employee: $336,175
• Employees: 183
• Market Cap: 410.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	210.78M	81.77M	63.38%
Dec 31, 2023	129.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-